About BioAscent
BioAscent is a company based in Motherwell (United Kingdom) founded in 2013. BioAscent has raised $3.7 million across 3 funding rounds from investors including Maven Capital Partners. The company has 41 employees as of January 31, 2020. BioAscent offers products and services including Integrated Drug Discovery, Medicinal Chemistry, Compound Screening, and Computational Chemistry. BioAscent operates in a competitive market with competitors including McKesson, Resilience, Entero Healthcare, Zhejiang Mingdu Zhikong Technology and ASP Isotopes, among others.
- Headquarter Motherwell, United Kingdom
- Employees 41 as on 31 Jan, 2020
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioascent Discovery Limited
- Date of Incorporation 15 Feb, 2013
- Jurisdiction EDINBURGH, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.7 M (USD)
in 3 rounds
-
Latest Funding Round
$3.7 M (USD), Seed
Jun 20, 2018
- Investors
-
Employee Count
41
as on Jan 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioAscent
BioAscent offers a comprehensive portfolio of products and services, including Integrated Drug Discovery, Medicinal Chemistry, Compound Screening, and Computational Chemistry.
Comprehensive projects for developing new drugs
Design and synthesis of chemical compounds
High-throughput testing of potential drug candidates
Data analysis to accelerate drug design processes
People of BioAscent
Unlock access to complete
Unlock access to complete
Funding Insights of BioAscent
BioAscent has successfully raised a total of $3.7M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $3.7 million completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioAscent
BioAscent has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Maven Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for private equity investments.
|
Locked | Locked | Locked |
Investor details for BioAscent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioAscent
Investment portfolio details for BioAscent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioAscent
Detailed financials for BioAscent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioascent Comparisons
Peer comparison for BioAscent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioAscent
BioAscent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as McKesson, Resilience, Entero Healthcare, Zhejiang Mingdu Zhikong Technology and ASP Isotopes, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Products and services are provided in the healthcare industry.
|
|
| Locked | Locked | Locked |
Supply chain services for biopharma sector are provided.
|
|
| Locked | Locked | Locked |
India's leading healthcare products distribution platform
|
|
| Locked | Locked | Locked |
AI-based logistics services are provided in Hangzhou, China.
|
|
| Locked | Locked | Locked |
Supply chain solution services for isotope production are provided.
|
Detailed competitors of BioAscent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioascent
Complete news archive for BioAscent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioAscent
BioAscent was founded in 2013.
BioAscent is headquartered in Motherwell, United Kingdom. It is registered at Motherwell, Scotland, United Kingdom.
BioAscent is a funded company, having raised a total of $3.7M across 3 funding rounds to date.
As of Jan 31, 2020, the latest employee count at BioAscent is 41.
BioAscent was established in 2013 in Motherwell, United Kingdom, focusing on compound management within the drug discovery sector. Services provided include compound management, Compound Cloud, compound collection sharing, and disaster recovery. Operations are conducted from a former automated facility of Merck. A confidential partner-matching service is facilitated to enable sharing of compound collections with pharmaceutical, biotechnology, and academic institutions under owner-specified terms.
BioAscent's top competitors include Entero Healthcare, McKesson and Resilience.
BioAscent offers Integrated Drug Discovery, Medicinal Chemistry, Compound Screening, and Computational Chemistry.
BioAscent has 1 investor. Key investors include Maven Capital Partners.
The valuation of BioAscent is $4.22M as of Jun 2018.